 HIV-1
"HIV-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.
| Descriptor ID |
D015497
|
| MeSH Number(s) |
B04.820.650.589.650.350.400 B04.909.777.731.589.650.350.400
|
| Concept/Terms |
HIV-1- HIV-1
- Immunodeficiency Virus Type 1, Human
- Human Immunodeficiency Virus Type 1
- HIV-I
- Human immunodeficiency virus 1
|
Below are MeSH descriptors whose meaning is more general than "HIV-1".
Below are MeSH descriptors whose meaning is more specific than "HIV-1".
This graph shows the total number of publications written about "HIV-1" by people in this website by year, and whether "HIV-1" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1988 | 1 | 0 | 1 | | 1991 | 4 | 0 | 4 | | 1992 | 4 | 0 | 4 | | 1993 | 6 | 0 | 6 | | 1994 | 7 | 1 | 8 | | 1995 | 2 | 4 | 6 | | 1996 | 1 | 2 | 3 | | 1997 | 4 | 0 | 4 | | 1998 | 2 | 2 | 4 | | 1999 | 4 | 0 | 4 | | 2000 | 3 | 0 | 3 | | 2001 | 2 | 2 | 4 | | 2002 | 4 | 2 | 6 | | 2003 | 4 | 1 | 5 | | 2004 | 1 | 1 | 2 | | 2005 | 0 | 3 | 3 | | 2006 | 5 | 0 | 5 | | 2007 | 4 | 1 | 5 | | 2008 | 2 | 2 | 4 | | 2009 | 4 | 2 | 6 | | 2010 | 1 | 2 | 3 | | 2011 | 4 | 3 | 7 | | 2012 | 3 | 4 | 7 | | 2013 | 1 | 1 | 2 | | 2014 | 2 | 0 | 2 | | 2015 | 3 | 0 | 3 | | 2016 | 8 | 1 | 9 | | 2017 | 4 | 3 | 7 | | 2018 | 9 | 0 | 9 | | 2019 | 3 | 1 | 4 | | 2020 | 3 | 1 | 4 | | 2021 | 3 | 1 | 4 | | 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV-1" by people in Profiles.
-
Wymant C, Bezemer D, Blanquart F, Ferretti L, Gall A, Hall M, Golubchik T, Bakker M, Ong SH, Zhao L, Bonsall D, de Cesare M, MacIntyre-Cockett G, Abeler-Dörner L, Albert J, Bannert N, Fellay J, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos RD, Laeyendecker O, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Kellam P, Cornelissen M, Reiss P, Fraser C. A highly virulent variant of HIV-1 circulating in the Netherlands. Science. 2022 02 04; 375(6580):540-545.
-
Chen YT, Duncan DT, Del Vecchio N, Timmins L, Pagkas-Bather J, Lacap S, Hotton A, Knox J, Hanson H, Koli K, Durrell M, Dehlin J, Schneider JA. COVID-19-Related Stressors, Sex Behaviors, and HIV Status Neutral Care Among Black Men Who Have Sex With Men and Transgender Women in Chicago, USA. J Acquir Immune Defic Syndr. 2021 11 01; 88(3):261-271.
-
Masters MC, Cohn SE. Two-drug HIV regimens: more data still needed. Lancet HIV. 2021 08; 8(8):e454-e455.
-
Rosebush JC, Best BM, Chadwick EG, Butler K, Moye J, Smith E, Bradford S, Reding CA, Mathiba SR, Hanley S, Aziz M, Homans J, Acosta EP, Murtaugh W, Vourvahis M, Mcfadyen L, Hayward K, Mirochnick M, Samson P. Pharmacokinetics and safety of maraviroc in neonates. AIDS. 2021 03 01; 35(3):419-427.
-
Haberer JE, Bukusi EA, Mugo NR, Pyra M, Kiptinness C, Oware K, Garrison LE, Thomas KK, Musinguzi N, Morrison S, Anderson PL, Ngure K, Baeten JM. Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial. Lancet HIV. 2021 03; 8(3):e130-e137.
-
Dabitao D, Dembele M, Urbanowski M, Kone B, Wague M, Coulibaly N, Sarro YDS, Baya B, Goita D, Dao S, Belson M, Klein SL, Achenbach C, Holl JL, Diakite M, Doumbia S, Bream JH, Bishai WR, Diallo S, Murphy RL. Short Communication: Genetic Variation in Human IL10 Proximal Promoter and Susceptibility to HIV-1 Infection in Mali, West Africa. AIDS Res Hum Retroviruses. 2021 01; 37(1):57-61.
-
Hirschhorn LR, Brown RN, Friedman EE, Greene GJ, Bender A, Christeller C, Bouris A, Johnson AK, Pickett J, Modali L, Ridgway JP. Black Cisgender Women's PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago. J Acquir Immune Defic Syndr. 2020 08 15; 84(5):497-507.
-
Vasylyeva TI, Zarebski A, Smyrnov P, Williams LD, Korobchuk A, Liulchuk M, Zadorozhna V, Nikolopoulos G, Paraskevis D, Schneider J, Skaathun B, Pybus OG, Friedman SR. Phylodynamics Helps to Evaluate the Impact of an HIV Prevention Intervention. Viruses. 2020 04 20; 12(4).
-
Jurczyszak D, Zhang W, Terry SN, Kehrer T, Bermúdez González MC, McGregor E, Mulder LCF, Eckwahl MJ, Pan T, Simon V. HIV protease cleaves the antiviral m6A reader protein YTHDF3 in the viral particle. PLoS Pathog. 2020 02; 16(2):e1008305.
-
Barakat E, Oren NC, Vaysberg A. Symptomatic cerebrospinal fluid HIV escape syndrome in a patient on highly active antiretroviral therapy and suppressed plasma viral load. AIDS. 2019 12 01; 33(15):2444-2446.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|